Matrix Analytics releases new software to better manage patients and data

Tuesday November 21, 2017 0 comments Tags: Denver, Matrix Analytics, LungDirect v3.0, SmartFlow, Dr. Akrum Alzubaidi

DENVER -- Matrix Analytics announced the release of Version 3.0 of its revolutionary pulmonary incidentaloma and lung screening management software.matrix-analytics-logo

LungDirect v3.0 includes new feature SmartFlow, an innovative and time efficient way for providers to manage patients and patient data, the company said.

SmartFlow allows users to customize their roles and assignments within the application, effectively providing individualized workflows and management of tasks. A revamped user interface and enhanced patient letter templates improve upon current workflows, while machine automation unburdens users from low level tasks, allowing providers to focus at the top of their license.

Version 3.0 represents the second major overhaul of LungDirect since its June 2016 launch, and because of its cloud-based infrastructure, all updates are rolled out seamlessly and at no extra cost to hospitals, the company said.

"We were very intentional with our SmartFlow development,” said Dr. Akrum Alzubaidi, Matrix founder and an interventional pulmonologist at National Jewish Health.

“V3.0 addresses both the clinical and end user need to optimize patient care. Our current customers report spending a quarter of the time managing the same patient population with LungDirect as they did prior to the application. The machine automation within Version 3.0 will decrease the time spent even further.

“Additionally, recent data shows there is a 50% increase in clinical guideline follow-up just by sending a follow-up letter to a patient. SmartFlow automates patient letter population, reducing the number of patients lost to follow-up."

Matrix Analytics said it is focused on increasing the distribution of LungDirect, which will be deployed in 20 hospitals nationwide by the end of 2017.

The company said this marks a significant milestone in helping healthcare systems manage the 1.5 million pulmonary nodules that are detected incidentally by CT scans each year.  

Currently, 85% of all lung cancer patients are identified late-stage when the mortality rate is very high.

Matrix Analytics said it is committed to improving upon these statistics through efficient, accurate and time-saving workflows and machine automation.